These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 17204833

  • 1. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
    Whaley-Connell AT, Morris EM, Rehmer N, Yaghoubian JC, Wei Y, Hayden MR, Habibi J, Stump CS, Sowers JR.
    Am J Nephrol; 2007; 27(1):15-23. PubMed ID: 17204833
    [Abstract] [Full Text] [Related]

  • 2. TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species.
    Jin S, Ray RM, Johnson LR.
    Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G928-37. PubMed ID: 18218673
    [Abstract] [Full Text] [Related]

  • 3. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Custodis F, Eberl M, Kilter H, Böhm M, Laufs U.
    Cardiovasc Res; 2006 Jul 15; 71(2):342-51. PubMed ID: 16698001
    [Abstract] [Full Text] [Related]

  • 4. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells.
    Verhulst A, D'Haese PC, De Broe ME.
    J Am Soc Nephrol; 2004 Sep 15; 15(9):2249-57. PubMed ID: 15339974
    [Abstract] [Full Text] [Related]

  • 5. Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.
    Ceolotto G, Gallo A, Papparella I, Franco L, Murphy E, Iori E, Pagnin E, Fadini GP, Albiero M, Semplicini A, Avogaro A.
    Arterioscler Thromb Vasc Biol; 2007 Dec 15; 27(12):2627-33. PubMed ID: 17916771
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells.
    Sidaway JE, Davidson RG, McTaggart F, Orton TC, Scott RC, Smith GJ, Brunskill NJ.
    J Am Soc Nephrol; 2004 Sep 15; 15(9):2258-65. PubMed ID: 15339975
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    Whaley-Connell A, DeMarco VG, Lastra G, Manrique C, Nistala R, Cooper SA, Westerly B, Hayden MR, Wiedmeyer C, Wei Y, Sowers JR.
    Am J Nephrol; 2008 Sep 15; 28(1):67-75. PubMed ID: 17914247
    [Abstract] [Full Text] [Related]

  • 8. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
    Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, Laufs U.
    Circulation; 2003 Sep 30; 108(13):1567-74. PubMed ID: 12963641
    [Abstract] [Full Text] [Related]

  • 9. mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.
    Koch T, Seifert A, Wu DF, Rankovic M, Kraus J, Börner C, Brandenburg LO, Schröder H, Höllt V.
    J Neurochem; 2009 Aug 30; 110(4):1288-96. PubMed ID: 19519662
    [Abstract] [Full Text] [Related]

  • 10. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J, Wang Y, Zheng D, Wei M, Xu H, Peng T.
    Cardiovasc Res; 2013 Jan 01; 97(1):77-87. PubMed ID: 23027656
    [Abstract] [Full Text] [Related]

  • 11. Human proximal tubular epithelium actively secretes but does not retain rosuvastatin.
    Verhulst A, Sayer R, De Broe ME, D'Haese PC, Brown CD.
    Mol Pharmacol; 2008 Oct 01; 74(4):1084-91. PubMed ID: 18612079
    [Abstract] [Full Text] [Related]

  • 12. Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction.
    Moniri NH, Daaka Y.
    Biochem Pharmacol; 2007 Jun 30; 74(1):64-73. PubMed ID: 17451656
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
    Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, DeMarco VG, Andresen BT, Wei Y, Ferrario C, Sowers JR.
    Hypertension; 2008 Feb 30; 51(2):474-80. PubMed ID: 18172055
    [Abstract] [Full Text] [Related]

  • 14. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
    Pignatelli P, Carnevale R, Di Santo S, Bartimoccia S, Nocella C, Vicario T, Loffredo L, Angelico F, Violi F.
    Biochem Pharmacol; 2012 Dec 15; 84(12):1635-42. PubMed ID: 23022230
    [Abstract] [Full Text] [Related]

  • 15. NADPH oxidase-mediated Rac1 GTP activity is necessary for nongenomic actions of the mineralocorticoid receptor in the CA1 region of the rat hippocampus.
    Kawakami-Mori F, Shimosawa T, Mu S, Wang H, Ogura S, Yatomi Y, Fujita T.
    Am J Physiol Endocrinol Metab; 2012 Feb 15; 302(4):E425-32. PubMed ID: 22114025
    [Abstract] [Full Text] [Related]

  • 16. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism.
    Ito M, Adachi T, Pimentel DR, Ido Y, Colucci WS.
    Circulation; 2004 Jul 27; 110(4):412-8. PubMed ID: 15262848
    [Abstract] [Full Text] [Related]

  • 17. Neuregulin induces HaCaT keratinocyte migration via Rac1-mediated NADPH-oxidase activation.
    Kim JS, Bak EJ, Lee BC, Kim YS, Park JB, Choi IG.
    J Cell Physiol; 2011 Nov 27; 226(11):3014-21. PubMed ID: 21302299
    [Abstract] [Full Text] [Related]

  • 18. Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells.
    Muzaffar S, Shukla N, Bond M, Newby AC, Angelini GD, Sparatore A, Del Soldato P, Jeremy JY.
    J Vasc Res; 2008 Nov 27; 45(6):521-8. PubMed ID: 18463417
    [Abstract] [Full Text] [Related]

  • 19. Endothelins and NADPH oxidases in the cardiovascular system.
    Dammanahalli KJ, Sun Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 27; 35(1):2-6. PubMed ID: 18047620
    [Abstract] [Full Text] [Related]

  • 20. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
    Piconi L, Corgnali M, Da Ros R, Assaloni R, Piliego T, Ceriello A.
    J Diabetes Complications; 2008 Jan 27; 22(1):38-45. PubMed ID: 18191076
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.